“Noncognitive” symptoms of early Alzheimer disease
A longitudinal analysis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 16, 2014
- Accepted in final form October 10, 2014
- First Published January 14, 2015.
Article Versions
- Previous version (January 14, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Mary Clare Masters, MD,
- John C. Morris, MD and
- Catherine M. Roe, PhD
- Mary Clare Masters, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John C. Morris, MD and
Lilly USA
NONE
NONE
Serves on the editorial advisory board of JAMA Neurology
NONE
1. Blackwell Publishing, 2009, for Burns J and Morris JC, “Mild Cognitive Impairment and Early Alzheimer's Disease”, copyright 2008 by John Wiley and Sons, Ltd 2. Taylor & Francis 2008; “Handbook of Dementing Illnesses, 2 Ed”, Morris JC, Galvin JE, Holtzman DM, Eds, copyright 2006
NONE
NONE
NONE
NONE
NONE
Receives research support from Eli Lilly/Avid Radiopharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Catherine M. Roe, PhD
NONE
NONE
NONE
NONE
NONE
NONE
Salary support from NIH/NIA (R01 AG04343401, R01 AG15928- 02, P50-AG05681, P50-AG0568129 and P01- AG03991), the Longer Life Foundation, from the Charles and Joanne Knight Alzheimer Research Initiative of the Knight Alzheimer?s Disease Research Center, The Farrell Family Research Fund, and The generous support of F Simmons and O Mohan.
NONE
NONE
NONE
NONE
NONE
Salary support from NIH/NIA (R01 AG04343401, R01 AG15928- 02, P50-AG05681, P50-AG0568129 and P01- AG03991),
NONE
The Charles and Joanne Knight Alzheimer Research Initiative of the Knight Alzheimer?s Disease Research Center, the Longer Life Foundation, The Farrell Family Research Fund, and The generous support of F Simmons and O Mohan
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (J.C.M., C.M.R.), Pathology and Immunology (J.C.M.), Physical Therapy (J.C.M.), and Occupational Therapy (J.C.M.), and Knight Alzheimer's Disease Research Center (J.C.M., C.M.R.), Washington University School of Medicine (M.C.M., J.C.M., C.M.R.), St. Louis, MO.
- Correspondence to Dr. Roe: cathyr{at}wustl.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer DiseaseDenis S. Smirnov, Douglas Galasko, Annie Hiniker et al.Neurology, March 15, 2021 -
Article
Cognitive heterogeneity in probable Alzheimer diseaseClinical and neuropathologic featuresYuqi Qiu, Diane M. Jacobs, Karen Messer et al.Neurology, July 18, 2019 -
Article
Clinicopathologic differences among patients with behavioral variant frontotemporal dementiaMario F. Mendez, Aditi Joshi, Kanida Tassniyom et al.Neurology, January 16, 2013 -
Article
CSF biomarkers of Alzheimer disease“Noncognitive” outcomesCatherine M. Roe, Anne M. Fagan, Elizabeth A. Grant et al.Neurology, November 08, 2013